Mehdi Jafari

Bio: 
Mehdi Jafari is a PhD candidate in Epidemiology (Population and Public Health) at the University of British Columbia (UBC), School of Population and Public Health (SPPH). His research is at the forefront of cystic fibrosis care, focusing on the real-world impacts of innovative therapies like Elexacaftor/Tezacaftor/Ivacaftor (ETI). With a background in epidemiology and health services research, Mehdi is dedicated to improving healthcare outcomes and optimizing treatment strategies for patients with chronic conditions. His work bridges the gap between clinical innovation and healthcare policy, aiming to enhance the quality of life for patients and contribute to evidence-based healthcare practices.